Growth rate of pancreatic adenocarcinoma: initial clinical experience
A better understanding of the growth rate of pancreatic carcinoma is important in determining its natural course and in evaluating the effects of treatment or prognosis. The authors studied the growth rate of pancreatic carcinoma and the relation between its tumor volume doubling time (TVDT) and hos...
Gespeichert in:
| Veröffentlicht in: | Pancreas 2001-05, Vol.22 (4), p.366-369 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 369 |
|---|---|
| container_issue | 4 |
| container_start_page | 366 |
| container_title | Pancreas |
| container_volume | 22 |
| creator | FURUKAWA, Hiroyoshi IWATA, Ryoko MORIYAMA, Noriyuki |
| description | A better understanding of the growth rate of pancreatic carcinoma is important in determining its natural course and in evaluating the effects of treatment or prognosis. The authors studied the growth rate of pancreatic carcinoma and the relation between its tumor volume doubling time (TVDT) and host survival. Nine patients with pancreatic carcinoma who underwent serial examinations by helical computed tomography but no anticancer treatment during the observation period were included. The TVDTs were calculated by measuring the tumor size on the helical computed tomograms. The mean TVDT of the nine primary lesions of pancreatic carcinoma was 159 +/- 67 days (median, 144 days), and the range was 64 to 255 days. The correlation between TVDT and survival time was positive and significant (r = 0.793, p = 0.011). This preliminary study suggests that examination of TVDT may be useful in the clinical evaluation of prognosis for patients with pancreatic carcinoma in certain situations. |
| doi_str_mv | 10.1097/00006676-200105000-00005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70845687</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70845687</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-bd593f5418ed3d858a57898b736b3b8db087b7579070396f4d015c0ae64a30123</originalsourceid><addsrcrecordid>eNpFkEtLAzEQgIMotlb_giwI3laT5jGJNym1CgUvel6y2VmM7Mtki_rvTW2tc5kH38zAR0jG6A2jBm5pCqVA5XNKGZWpy7cjeUSmTHKVCz3Xx2RKtZY5ZwATchbje2KBS3NKJoxxIRlXU7Jchf5zfMuCHTHr62ywnQtoR-8yW2HXOxuc7_rW3mW-86O3TeaaVLlU4NeAwWPn8Jyc1LaJeLHPM_L6sHxZPObr59XT4n6dO8HFmJeVNLyWgmmseKWlthK00SVwVfJSVyXVUIIEQ4Fyo2pRUSYdtaiE5ZTN-Yxc7-4Oof_YYByL1keHTWM77DexAKqFVBoSqHegC32MAetiCL614btgtNgqLP4UFgeFvyOZVi_3PzZli9X_4t5ZAq72gI1JQx2SMh8PnAGQBvgP8yN3gw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70845687</pqid></control><display><type>article</type><title>Growth rate of pancreatic adenocarcinoma: initial clinical experience</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>FURUKAWA, Hiroyoshi ; IWATA, Ryoko ; MORIYAMA, Noriyuki</creator><creatorcontrib>FURUKAWA, Hiroyoshi ; IWATA, Ryoko ; MORIYAMA, Noriyuki</creatorcontrib><description>A better understanding of the growth rate of pancreatic carcinoma is important in determining its natural course and in evaluating the effects of treatment or prognosis. The authors studied the growth rate of pancreatic carcinoma and the relation between its tumor volume doubling time (TVDT) and host survival. Nine patients with pancreatic carcinoma who underwent serial examinations by helical computed tomography but no anticancer treatment during the observation period were included. The TVDTs were calculated by measuring the tumor size on the helical computed tomograms. The mean TVDT of the nine primary lesions of pancreatic carcinoma was 159 +/- 67 days (median, 144 days), and the range was 64 to 255 days. The correlation between TVDT and survival time was positive and significant (r = 0.793, p = 0.011). This preliminary study suggests that examination of TVDT may be useful in the clinical evaluation of prognosis for patients with pancreatic carcinoma in certain situations.</description><identifier>ISSN: 0885-3177</identifier><identifier>EISSN: 1536-4828</identifier><identifier>DOI: 10.1097/00006676-200105000-00005</identifier><identifier>PMID: 11345136</identifier><identifier>CODEN: PANCE4</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Adenocarcinoma - mortality ; Adenocarcinoma - pathology ; Aged ; Biological and medical sciences ; CA-19-9 Antigen - blood ; Digestive system ; Female ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Male ; Medical sciences ; Middle Aged ; Neoplasm Recurrence, Local ; Pancreatic Neoplasms - mortality ; Pancreatic Neoplasms - pathology ; Radiodiagnosis. Nmr imagery. Nmr spectrometry ; Survival Rate ; Time Factors ; Tomography, X-Ray Computed</subject><ispartof>Pancreas, 2001-05, Vol.22 (4), p.366-369</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-bd593f5418ed3d858a57898b736b3b8db087b7579070396f4d015c0ae64a30123</citedby><cites>FETCH-LOGICAL-c434t-bd593f5418ed3d858a57898b736b3b8db087b7579070396f4d015c0ae64a30123</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=977597$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11345136$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FURUKAWA, Hiroyoshi</creatorcontrib><creatorcontrib>IWATA, Ryoko</creatorcontrib><creatorcontrib>MORIYAMA, Noriyuki</creatorcontrib><title>Growth rate of pancreatic adenocarcinoma: initial clinical experience</title><title>Pancreas</title><addtitle>Pancreas</addtitle><description>A better understanding of the growth rate of pancreatic carcinoma is important in determining its natural course and in evaluating the effects of treatment or prognosis. The authors studied the growth rate of pancreatic carcinoma and the relation between its tumor volume doubling time (TVDT) and host survival. Nine patients with pancreatic carcinoma who underwent serial examinations by helical computed tomography but no anticancer treatment during the observation period were included. The TVDTs were calculated by measuring the tumor size on the helical computed tomograms. The mean TVDT of the nine primary lesions of pancreatic carcinoma was 159 +/- 67 days (median, 144 days), and the range was 64 to 255 days. The correlation between TVDT and survival time was positive and significant (r = 0.793, p = 0.011). This preliminary study suggests that examination of TVDT may be useful in the clinical evaluation of prognosis for patients with pancreatic carcinoma in certain situations.</description><subject>Adenocarcinoma - mortality</subject><subject>Adenocarcinoma - pathology</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>CA-19-9 Antigen - blood</subject><subject>Digestive system</subject><subject>Female</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local</subject><subject>Pancreatic Neoplasms - mortality</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Radiodiagnosis. Nmr imagery. Nmr spectrometry</subject><subject>Survival Rate</subject><subject>Time Factors</subject><subject>Tomography, X-Ray Computed</subject><issn>0885-3177</issn><issn>1536-4828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtLAzEQgIMotlb_giwI3laT5jGJNym1CgUvel6y2VmM7Mtki_rvTW2tc5kH38zAR0jG6A2jBm5pCqVA5XNKGZWpy7cjeUSmTHKVCz3Xx2RKtZY5ZwATchbje2KBS3NKJoxxIRlXU7Jchf5zfMuCHTHr62ywnQtoR-8yW2HXOxuc7_rW3mW-86O3TeaaVLlU4NeAwWPn8Jyc1LaJeLHPM_L6sHxZPObr59XT4n6dO8HFmJeVNLyWgmmseKWlthK00SVwVfJSVyXVUIIEQ4Fyo2pRUSYdtaiE5ZTN-Yxc7-4Oof_YYByL1keHTWM77DexAKqFVBoSqHegC32MAetiCL614btgtNgqLP4UFgeFvyOZVi_3PzZli9X_4t5ZAq72gI1JQx2SMh8PnAGQBvgP8yN3gw</recordid><startdate>20010501</startdate><enddate>20010501</enddate><creator>FURUKAWA, Hiroyoshi</creator><creator>IWATA, Ryoko</creator><creator>MORIYAMA, Noriyuki</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010501</creationdate><title>Growth rate of pancreatic adenocarcinoma: initial clinical experience</title><author>FURUKAWA, Hiroyoshi ; IWATA, Ryoko ; MORIYAMA, Noriyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-bd593f5418ed3d858a57898b736b3b8db087b7579070396f4d015c0ae64a30123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adenocarcinoma - mortality</topic><topic>Adenocarcinoma - pathology</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>CA-19-9 Antigen - blood</topic><topic>Digestive system</topic><topic>Female</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local</topic><topic>Pancreatic Neoplasms - mortality</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Radiodiagnosis. Nmr imagery. Nmr spectrometry</topic><topic>Survival Rate</topic><topic>Time Factors</topic><topic>Tomography, X-Ray Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FURUKAWA, Hiroyoshi</creatorcontrib><creatorcontrib>IWATA, Ryoko</creatorcontrib><creatorcontrib>MORIYAMA, Noriyuki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pancreas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FURUKAWA, Hiroyoshi</au><au>IWATA, Ryoko</au><au>MORIYAMA, Noriyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Growth rate of pancreatic adenocarcinoma: initial clinical experience</atitle><jtitle>Pancreas</jtitle><addtitle>Pancreas</addtitle><date>2001-05-01</date><risdate>2001</risdate><volume>22</volume><issue>4</issue><spage>366</spage><epage>369</epage><pages>366-369</pages><issn>0885-3177</issn><eissn>1536-4828</eissn><coden>PANCE4</coden><abstract>A better understanding of the growth rate of pancreatic carcinoma is important in determining its natural course and in evaluating the effects of treatment or prognosis. The authors studied the growth rate of pancreatic carcinoma and the relation between its tumor volume doubling time (TVDT) and host survival. Nine patients with pancreatic carcinoma who underwent serial examinations by helical computed tomography but no anticancer treatment during the observation period were included. The TVDTs were calculated by measuring the tumor size on the helical computed tomograms. The mean TVDT of the nine primary lesions of pancreatic carcinoma was 159 +/- 67 days (median, 144 days), and the range was 64 to 255 days. The correlation between TVDT and survival time was positive and significant (r = 0.793, p = 0.011). This preliminary study suggests that examination of TVDT may be useful in the clinical evaluation of prognosis for patients with pancreatic carcinoma in certain situations.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>11345136</pmid><doi>10.1097/00006676-200105000-00005</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0885-3177 |
| ispartof | Pancreas, 2001-05, Vol.22 (4), p.366-369 |
| issn | 0885-3177 1536-4828 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70845687 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Adenocarcinoma - mortality Adenocarcinoma - pathology Aged Biological and medical sciences CA-19-9 Antigen - blood Digestive system Female Humans Investigative techniques, diagnostic techniques (general aspects) Male Medical sciences Middle Aged Neoplasm Recurrence, Local Pancreatic Neoplasms - mortality Pancreatic Neoplasms - pathology Radiodiagnosis. Nmr imagery. Nmr spectrometry Survival Rate Time Factors Tomography, X-Ray Computed |
| title | Growth rate of pancreatic adenocarcinoma: initial clinical experience |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T05%3A39%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Growth%20rate%20of%20pancreatic%20adenocarcinoma:%20initial%20clinical%20experience&rft.jtitle=Pancreas&rft.au=FURUKAWA,%20Hiroyoshi&rft.date=2001-05-01&rft.volume=22&rft.issue=4&rft.spage=366&rft.epage=369&rft.pages=366-369&rft.issn=0885-3177&rft.eissn=1536-4828&rft.coden=PANCE4&rft_id=info:doi/10.1097/00006676-200105000-00005&rft_dat=%3Cproquest_cross%3E70845687%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70845687&rft_id=info:pmid/11345136&rfr_iscdi=true |